AD

Capmatinib(CAS: 1029712-80-8)

Capmatinib
CAS Number

Related Products

Other Suppliers for Capmatinib

Basic Information

Molecular Formula
C23H17FN6O
Molecular Weight
412.43 g/mol

Chemical Identifiers

SMILES
CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F
InChIKey
LIOLIMKSCNQPLV-UHFFFAOYSA-N

Database References

MDL Number
MFCD18633285

FAQ

Capmatinib is a small molecule tyrosine kinase inhibitor. It has the chemical formula C20H19FN5O2. Capmatinib selectively targets the MET receptor tyrosine kinase, which is overexpressed in certain cancers.
Capmatinib is primarily used in the treatment of non-small cell lung cancer (NSCLC) with MET exon 14 skipping mutations. It is also being studied for its potential use in other cancers.
Capmatinib is generally safe when used as directed. However, it can cause side effects such as diarrhea, fatigue, and nausea. Patients should be monitored for these effects and other potential issues. Proper handling and storage are essential to avoid exposure risks.
Capmatinib should be stored at room temperature, between 15-30°C (59-86°F), in a tightly sealed container. Avoid exposure to moisture and light. Keep out of reach of children and ensure it is stored in a secure location.

Safety Notice

Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.

Always follow proper handling procedures

Contact Information

Email

2851167780@qq.com

Mobile

13348961525

Fax

028-81705658